207 related articles for article (PubMed ID: 21714127)
1. Resveratrol and prostate cancer: promising role for microRNAs.
Dhar S; Hicks C; Levenson AS
Mol Nutr Food Res; 2011 Aug; 55(8):1219-29. PubMed ID: 21714127
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer.
Dhar S; Kumar A; Rimando AM; Zhang X; Levenson AS
Oncotarget; 2015 Sep; 6(29):27214-26. PubMed ID: 26318586
[TBL] [Abstract][Full Text] [Related]
3. miR-200a, miR-200b and miR-429 are onco-miRs that target the PTEN gene in endometrioid endometrial carcinoma.
Yoneyama K; Ishibashi O; Kawase R; Kurose K; Takeshita T
Anticancer Res; 2015 Mar; 35(3):1401-10. PubMed ID: 25750291
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol and pterostilbene as a microRNA-mediated chemopreventive and therapeutic strategy in prostate cancer.
Kumar A; Rimando AM; Levenson AS
Ann N Y Acad Sci; 2017 Sep; 1403(1):15-26. PubMed ID: 28662290
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol suppresses melanoma by inhibiting NF-κB/miR-221 and inducing TFG expression.
Wu F; Cui L
Arch Dermatol Res; 2017 Dec; 309(10):823-831. PubMed ID: 28936555
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways.
Wang G; Dai F; Yu K; Jia Z; Zhang A; Huang Q; Kang C; Jiang H; Pu P
Int J Oncol; 2015 Apr; 46(4):1739-47. PubMed ID: 25646654
[TBL] [Abstract][Full Text] [Related]
7. Exosome-derived microRNAs contribute to prostate cancer chemoresistance.
Li J; Yang X; Guan H; Mizokami A; Keller ET; Xu X; Liu X; Tan J; Hu L; Lu Y; Zhang J
Int J Oncol; 2016 Aug; 49(2):838-46. PubMed ID: 27278879
[TBL] [Abstract][Full Text] [Related]
8. Oncogene miR-106a promotes proliferation and metastasis of prostate cancer cells by directly targeting PTEN in vivo and in vitro.
Luo B; Kang N; Chen Y; Liu L; Zhang Y
Minerva Med; 2018 Feb; 109(1):24-30. PubMed ID: 28889725
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic potential of resveratrol and analogs in preclinical models of prostate cancer.
Kumar A; Dhar S; Rimando AM; Lage JM; Lewin JR; Zhang X; Levenson AS
Ann N Y Acad Sci; 2015 Aug; 1348(1):1-9. PubMed ID: 26214308
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.
Fuse M; Kojima S; Enokida H; Chiyomaru T; Yoshino H; Nohata N; Kinoshita T; Sakamoto S; Naya Y; Nakagawa M; Ichikawa T; Seki N
J Hum Genet; 2012 Nov; 57(11):691-9. PubMed ID: 22854542
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cell survival by resveratrol involves inhibition of NF kappa B-regulated gene expression in prostate cancer cells.
Benitez DA; Hermoso MA; Pozo-Guisado E; Fernández-Salguero PM; Castellón EA
Prostate; 2009 Jul; 69(10):1045-54. PubMed ID: 19301309
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-622 functions as a tumor suppressor by targeting K-Ras and enhancing the anticarcinogenic effect of resveratrol.
Han Z; Yang Q; Liu B; Wu J; Li Y; Yang C; Jiang Y
Carcinogenesis; 2012 Jan; 33(1):131-9. PubMed ID: 22016468
[TBL] [Abstract][Full Text] [Related]
13. Microarray-based analysis: identification of hypoxia-regulated microRNAs in retinoblastoma cells.
Xu X; Jia R; Zhou Y; Song X; Wang J; Qian G; Ge S; Fan X
Int J Oncol; 2011 May; 38(5):1385-93. PubMed ID: 21373755
[TBL] [Abstract][Full Text] [Related]
14. Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT.
Peng X; Guo W; Liu T; Wang X; Tu X; Xiong D; Chen S; Lai Y; Du H; Chen G; Liu G; Tang Y; Huang S; Zou X
PLoS One; 2011; 6(5):e20341. PubMed ID: 21647377
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).
Zhang JG; Wang JJ; Zhao F; Liu Q; Jiang K; Yang GH
Clin Chim Acta; 2010 Jun; 411(11-12):846-52. PubMed ID: 20223231
[TBL] [Abstract][Full Text] [Related]
16. miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN.
Xie X; Liu HT; Mei J; Ding FB; Xiao HB; Hu FQ; Hu R; Wang MS
Int J Clin Exp Pathol; 2015; 8(4):3827-34. PubMed ID: 26097565
[TBL] [Abstract][Full Text] [Related]
17. The PTEN/PI3K/Akt and Wnt/β-catenin signaling pathways are involved in the inhibitory effect of resveratrol on human colon cancer cell proliferation.
Liu YZ; Wu K; Huang J; Liu Y; Wang X; Meng ZJ; Yuan SX; Wang DX; Luo JY; Zuo GW; Yin LJ; Chen L; Deng ZL; Yang JQ; Sun WJ; He BC
Int J Oncol; 2014 Jul; 45(1):104-12. PubMed ID: 24756222
[TBL] [Abstract][Full Text] [Related]
18. Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing.
Song C; Chen H; Wang T; Zhang W; Ru G; Lang J
Prostate; 2015 Apr; 75(5):500-16. PubMed ID: 25597612
[TBL] [Abstract][Full Text] [Related]
19. Overexpressed miR-494 down-regulates PTEN gene expression in cells transformed by anti-benzo(a)pyrene-trans-7,8-dihydrodiol-9,10-epoxide.
Liu L; Jiang Y; Zhang H; Greenlee AR; Han Z
Life Sci; 2010 Jan; 86(5-6):192-8. PubMed ID: 20006626
[TBL] [Abstract][Full Text] [Related]
20. Importance of miR-20a expression in prostate cancer tissue.
Pesta M; Klecka J; Kulda V; Topolcan O; Hora M; Eret V; Ludvikova M; Babjuk M; Novak K; Stolz J; Holubec L
Anticancer Res; 2010 Sep; 30(9):3579-83. PubMed ID: 20944140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
